Complete pathological response with diabetic ketoacidosis to the combination of sintilimab and anlotinib in an unresectable hepatocellular carcinoma patient: a case report

Most hepatocellular carcinoma (HCC) patients have dismal prognoses because they are already in the advanced stage at the time of initial diagnosis and are unable to undergo upfront surgery. Recent studies of immune checkpoint inhibitors (ICIs) and antiangiogenic agents (AAAs) have shown encouraging...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Lingli, Chen, Ping, Wang, Shijie, Liu, Wenmin, Chen, Zubing, Chen, Hongbin, Fu, Zhenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670343/
https://www.ncbi.nlm.nih.gov/pubmed/34338239
http://dx.doi.org/10.1097/CAD.0000000000001163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670343/
https://www.ncbi.nlm.nih.gov/pubmed/34338239
http://dx.doi.org/10.1097/CAD.0000000000001163

Ejemplares similares